Patent · US Active

Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids

US9517273B2 · kind B2 · utility

16Cited by
171References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 7, 2015
Grant dateDec 13, 2016
Priority date—
Expiry dateApr 7, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified FGF-21 polypeptides and uses thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.